000766.SZ SHZ
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
1W: -4.7%
1M: -8.4%
3M: -17.0%
YTD: -35.4%
1Y: -32.3%
3Y: +179.7%
5Y: +211.3%
¥15.16 ($2.26)
-0.01 (-0.07%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$4.5B
-0.8% ▼
5Y CAGR: -0.9%
Total Liabilities
$2.2B
+1.2% ▲
5Y CAGR: +1.9%
Shareholders Equity
$2.3B
-2.7% ▼
5Y CAGR: -3.0%
Cash & Investments
$275M
+54.2% ▲
5Y CAGR: -0.5%
Total Debt
$198M
-88.3% ▼
5Y CAGR: -32.4%
Net Debt
-$77M
-105.1% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $508M | $302M | $337M | $177M | $274M |
| Short-Term Investments | $0 | $180K | $128K | $1M | $1M |
| Cash & ST Investments | $508M | $302M | $337M | $178M | $275M |
| Net Receivables | $459M | $444M | $506M | $555M | $542M |
| Inventory | $435M | $385M | $381M | $369M | $382M |
| Other Current Assets | $114M | $15M | $164K | $397K | $339K |
| Total Current Assets | $1.5B | $1.2B | $1.2B | $1.1B | $1.2B |
| Property, Plant & Equip. | $992M | $1.1B | $1.0B | $1.0B | $973M |
| Goodwill & Intangibles | $392M | $388M | $379M | $376M | $376M |
| Long-Term Investments | $2.0B | $2.0B | $2.0B | $2.0B | $1.8B |
| Other Non-Current Assets | $13M | $19M | $25M | $38M | $46M |
| Total Non-Current Assets | $3.4B | $3.5B | $3.4B | $3.4B | $3.3B |
| Total Assets | $5.0B | $4.6B | $4.7B | $4.5B | $4.5B |
| — Liabilities — | |||||
| Accounts Payable | $188M | $151M | $222M | $191M | $182M |
| Short-Term Debt | $288M | $1.7B | $230M | $130M | $195M |
| Deferred Revenue | $280M | $12M | $40M | $0 | $0 |
| Other Current Liabilities | -$246M | $1M | $180M | $256M | $1.6B |
| Total Current Liabilities | $764M | $2.0B | $672M | $572M | $2.2B |
| Long-Term Debt | $1.8B | $184M | $1.6B | $1.6B | $0 |
| Other Non-Current Liab. | -$4M | $0 | $0 | $69M | $0 |
| Total Non-Current Liabilities | $1.9B | $274M | $1.6B | $1.6B | $71M |
| Total Liabilities | $2.7B | $2.3B | $2.3B | $2.2B | $2.2B |
| — Equity — | |||||
| Common Stock | $966M | $966M | $966M | $966M | $966M |
| Retained Earnings | -$2.4B | -$2.4B | -$2.4B | -$2.3B | -$2.3B |
| Accumulated OCI | $786M | $786M | $0 | $786M | $667M |
| Total Stockholders Equity | $2.3B | $2.3B | $2.3B | $2.3B | $2.3B |
| Total Liabilities & Equity | $5.0B | $4.6B | $4.7B | $4.5B | $4.5B |
| — Key Metrics — | |||||
| Total Debt | $2.1B | $1.9B | $1.8B | $1.7B | $198M |
| Net Debt | $1.6B | $1.6B | $1.5B | $1.5B | -$77M |
| Total Investments | $2.0B | $2.0B | $2.0B | $2.0B | $1.8B |